Dishman Carbogen Amcis Limited
What company does?Pharmaceutical services and manufacturing
Established2007
Entity typePrivate
HeadquartersSwitzerland
SegmentB2B
Dishman Carbogen Amcis Limited is a share market listed company
in the Healthcare industry
.
It got listed on NSE on 21-SEP-2017 under the trading symbol DCAL.
On BSE it is listed under trading symbol DCAL.
The company operates in
Pharmaceuticals
,
Chemical Manufacturing
and
Contract Research & Development Services
categories.
Company overview
Dishman Carbogen Amcis Limited is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, manufacturing, and packaging services. The company specializes in the production of high potency active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms.
employs cutting-edge equipment for chemical synthesis such as hydrogenation reactors capable of handling high-pressure reactions often required during API manufacturing.
The Company distinguishes itself through its strong focus on quality management systems which are compliant with international regulatory standards like USFDA & EDQM.
Additionally,
they have established strategic collaborations with renowned pharma companies globally ensuring access to advanced technologies & scientific expertise while enhancing their market presence.
Overall,Dishman Carbogen Amcis continues to set itself apart from competitors through its robust infrastructure,dynamic R&D capabilities,and unwavering commitment toward sustainable practices along with fostering partnerships that drive continued growth within the pharmaceutical sector.
With state-of-the-art facilities in India, Switzerland, UK, and China, Dishman Carbogen Amcis provides innovative solutions for drug development and commercialization. Their comprehensive service offerings encompass process research and development, custom synthesis, cGMP manufacturing of APIs and drug products as well as formulation development.
The company's expertise lies in handling complex chemistry to deliver challenging molecules at all scales. They cater to various therapeutic areas including oncology, metabolic disorders, inflammation/infectious diseases among others. This broad spectrum enables them to meet diverse client requirements efficiently.
Dishman Carbogen Amcis has also made significant strides in green chemistry by developing eco-friendly processes that minimize environmental impact without compromising quality or efficiency. This commitment aligns with their dedication towards sustainability. In terms of technological innovation,